Therefore, adropin treatment appears to promote the preferential use of carbohydrates as an energy substrate, while reducing fatty acid oxidation; however, further research is still needed to finally clarify the molecular mechanisms that regulate the effects of adropin on carbohydrate-lipid metabolism in obesity. The gene discussed is ENHO; the disease is obesity disorder.